Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mannkind Corp (NQ: MNKD )

5.180 +0.020 (+0.39%)
Streaming Delayed Price Updated: 3:09 PM EST, Feb 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,037,104
Open 5.180
Bid (Size) 5.180 (9)
Ask (Size) 5.190 (29)
Prev. Close 5.160
Today's Range 5.100 - 5.220
52wk Range 2.490 - 5.510
Shares Outstanding 263,195,593
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
MannKind Corporation to Participate in the Lytham Partners Investor Select Conference
From MannKind
Via Globe NewsWire
MannKind’s Inhaled Clofazimine Will Advance to an Adaptive Phase 2/3 Study For Potential Treatment of Rare Lung Disease
From MannKind
Via Globe NewsWire

Performance

YTD
-0.58%
-0.58%
1 Month
+8.60%
+8.60%
3 Month
+42.70%
+42.70%
6 Month
+19.08%
+19.08%
1 Year
+37.40%
+37.40%

More News

Read More
3 Biotech Stocks Under $15 Worth a Second Look in 2023
Via The Motley Fool
MannKind's Return On Capital Employed Overview
Via Benzinga
MannKind Corporation (MNKD) Q3 2022 Earnings Call Transcript
Via The Motley Fool
MannKind: Q2 Earnings Insights
Via Benzinga
MannKind Corporation to Present at 2023 Annual J.P. Morgan Healthcare Conference
From MannKind
Via Globe NewsWire
MannKind to Present Two Posters at 22nd Annual Diabetes Technology Meeting
From MannKind
Via Globe NewsWire
MannKind To Rally 57%? Here Are 5 Other Price Target Changes For Wednesday
Via Benzinga
Tyson Foods To $61? Plus Needham Slashes PT On This Stock By 33%
Via Benzinga
MannKind Corporation Reports 2022 Third Quarter Financial Results
From MannKind
Via Globe NewsWire
Earnings Preview: MannKind
Via Benzinga
MannKind Corporation to Hold 2022 Third Quarter Financial Results Conference Call on November 8, 2022
From MannKind
Via Globe NewsWire
7 Penny Sleeper Stocks to Buy Before Wall Street Wakes Up
Via InvestorPlace
7 Penny Stocks That Actually Have a Buy Rating
Via InvestorPlace
MannKind Shares Fall After Completing Initial Stage Lung Disease Study
Via Benzinga
Earnings Outlook For MannKind
Via Benzinga
Jim Cramer Recommends Selling This Stock: 'No One Ever Likes Me To Say Anything Bad' About This Company
Via Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation
Via Benzinga
7 Biotech Stocks With Key Catalysts for May
Via InvestorPlace
MannKind Earnings Preview
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Market ETF Stocks to Buy This Week on Fed Jitters
Via InvestorPlace
4 Penny Stocks Insiders Are Buying: MannKind, Crexendo And More
Via Benzinga
68 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.